Do Cancer Patients Benefit by Participating in Clinical Trials?

Many oncologists, patients, cancer centres, and cancer professional societies regard participation in a cancer trial as a therapeutic option. These claims are often based, ironically, on anecdote and observational studies - precisely the kind of evidence clinical trials aim at superseding. In this talk, Dr Jonathan Kimmelman presents a series of philosophical and empirical analyses of the therapeutic value of trial participation. He closes by discussing some of the limitations of his analyses, and unpacking some of their ethical and policy implications.

Be sure to follow Consilium on:
Twitter: https://x.com/consiliumsci
LinkedIn:   / consilium-scientific  
Eventbrite: https://www.eventbrite.co.uk/o/consil...